Sunlenca approved for treatment-resistant populations, but a number of other drugs will cease production, some of which are included in PEP guidelines.
Sunlenca approved for treatment-resistant populations, but a number of other drugs will cease production, some of which are included in PEP guidelines.
Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.
Nine generic versions of Lyrica (pregabalin) have been approved for the treatment of five different medical conditions.
Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.
The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.
The opioid prodrug for acute pain will soon be available in both a stronger and weaker dose.
Five-to-ten times stronger than fentanyl, this drug is not for consumer use, and many claim it could worsen the opioid crisis.
